Acute Liver Failure Differential Diagnoses

1. [Guideline] Lee WM, Larson AM, Stravitz RT. AASLD position paper: the management of acute liver failure: update 2011. Hepatology. Available at https://www.aasld.org/sites/default/files/guideline_documents/alfenhanced.pdf. 2011; Accessed: June 13, 2017.

2. Lee WM, Stravitz RT, Larson AM. Introduction to the revised American Association for the Study of Liver Diseases position paper on acute liver failure 2011. Hepatology. 2012 Mar. 55(3):965-7. [Medline]. [Full Text].

3. Stravitz RT, Kramer AH, Davern T, et al, for the Acute Liver Failure Study Group. Intensive care of patients with acute liver failure: recommendations of the U.S. Acute Liver Failure Study Group. Crit Care Med. 2007 Nov. 35(11):2498-508. [Medline].

4. Bernal W. Intensive care support therapy. Liver Transpl. 2003 Sep. 9(9):S15-7. [Medline].

5. Jalan R. Acute liver failure: current management and future prospects. J Hepatol. 2005. 42 suppl (1):S115-23. [Medline].

6. Sussman NL, Gislason GT, Conlin CA, Kelly JH. The Hepatix extracorporeal liver assist device: initial clinical experience. Artif Organs. 1994 May. 18(5):390-6. [Medline].

7. Hughes RD, Williams R. Use of bioartificial and artificial liver support devices. Semin Liver Dis. 1996 Nov. 16(4):435-44. [Medline].

8. Nyberg SL, Misra SP. Hepatocyte liver-assist systems--a clinical update. Mayo Clin Proc. 1998 Aug. 73(8):765-71. [Medline].

9. Demetriou AA, Brown RS Jr, Busuttil RW, et al. Prospective, randomized, multicenter, controlled trial of a bioartificial liver in treating acute liver failure. Ann Surg. 2004 May. 239(5):660-7; discussion 667-70. [Medline]. [Full Text].

10. Jalan R, Olde Damink SW, Deutz NE, Hayes PC, Lee A. Moderate hypothermia in patients with acute liver failure and uncontrolled intracranial hypertension. Gastroenterology. 2004 Nov. 127(5):1338-46. [Medline].

11. Jiang W, Desjardins P, Butterworth RF. Hypothermia attenuates oxidative/nitrosative stress, encephalopathy and brain edema in acute (ischemic) liver failure. Neurochem Int. 2009 Jul-Aug. 55(1-3):124-8. [Medline].

12. Hoofnagle JH, Carithers RL Jr, Shapiro C, Ascher N. Fulminant hepatic failure: summary of a workshop. Hepatology. 1995 Jan. 21(1):240-52. [Medline].

13. Lee WM, Schiodt FV. Fulminant hepatic failure. In: Schiff ER, Sorrell, MF, Maddrey WC, eds. Schiff's Diseases of the Liver. 8th ed. Baltimore, Md: Lippincott Williams & Wilkins; 1999.

14. Lidofsky SD, Bass NM, Prager MC, et al. Intracranial pressure monitoring and liver transplantation for fulminant hepatic failure. Hepatology. 1992 Jul. 16(1):1-7. [Medline].

15. Detry O, Arkadopoulos N, Ting P, et al. Intracranial pressure during liver transplantation for fulminant hepatic failure. Transplantation. 1999 Mar 15. 67(5):767-70. [Medline].

16. Schiodt FV, Rochling FA, Casey DL, Lee WM. Acetaminophen toxicity in an urban county hospital. N Engl J Med. 1997 Oct 16. 337(16):1112-7. [Medline].

17. Larson AM, Polson J, Fontana RJ, et al, for the Acute Liver Failure Study Group. Acetaminophen-induced acute liver failure: results of a United States multicenter, prospective study. Hepatology. 2005 Dec. 42(6):1364-72. [Medline].

18. Davern TJ 2nd, James LP, Hinson JA, et al, for the Acute Liver Failure Study Group. Measurement of serum acetaminophen-protein adducts in patients with acute liver failure. Gastroenterology. 2006 Mar. 130(3):687-94. [Medline].

19. Khandelwal N, James LP, Sanders C, Larson AM, Lee WM, Acute Liver Failure Study Group. Unrecognized acetaminophen toxicity as a cause of indeterminate acute liver failure. Hepatology. 2011 Feb. 53(2):567-76. [Medline].

20. Galante A, Adeyi O, Lau L, et al. Liver transplantation for acute liver failure due to dengue fever: first successful reported case worldwide. Hepatology. 2019 Jun 4. [Medline].

21. Liu J, Ghaziani TT, Wolf JL. Acute fatty liver disease of pregnancy: updates in pathogenesis, diagnosis, and management. Am J Gastroenterol. 2017 Jun. 112(6):838-46. [Medline].

22. Alempijevic T, Zec S, Milosavljevic T. Drug-induced liver injury: do we know everything?. World J Hepatol. 2017 Apr 8. 9(10):491-502. [Medline].

23. Biolato M, Araneo C, Marrone G, et al. Liver transplantation for drug-induced acute liver failure. Eur Rev Med Pharmacol Sci. 2017 Mar. 21(1 suppl):37-45. [Medline].

24. Marrone G, Vaccaro FG, Biolato M, et al. Drug-induced liver injury 2017: the diagnosis is not easy but always to keep in mind. Eur Rev Med Pharmacol Sci. 2017 Mar. 21(1 Suppl):122-34. [Medline].

25. DiPaola F, Molleston JP, Gu J, et al, for the US Drug Induced Liver Injury Network. Antimicrobials and anti-epileptics are the leading causes of idiosyncratic drug induced liver injury in American children. J Pediatr Gastroenterol Nutr. 2019 May 6. [Medline].

26. Paterson JM, Mamdani MM, Manno M, Juurlink DN, Canadian Drug Safety and Effectiveness Research Network. Fluoroquinolone therapy and idiosyncratic acute liver injury: a population-based study. CMAJ. 2012 Oct 2. 184(14):1565-70. [Medline].

27. Centers for Disease Control and Prevention (CDC). Notes from the field: acute hepatitis and liver failure following the use of a dietary supplement intended for weight loss or muscle building--May-October 2013. MMWR Morb Mortal Wkly Rep. 2013 Oct 11. 62(40):817-9. [Medline]. [Full Text].

28. Hand L. CDC: supplement linked to hepatitis, liver failure. Medscape Medical News. October 15, 2013. [Full Text].

29. Lo Re V 3rd, Haynes K, Forde KA, et al. Risk of acute liver failure in patients with drug-induced liver injury: evaluation of Hy's law and a new prognostic model. Clin Gastroenterol Hepatol. 2015 Dec. 13(13):2360-8. [Medline].

30. Bernal W, Wang Y, Maggs J, et al. Development and validation of a dynamic outcome prediction model for paracetamol-induced acute liver failure: a cohort study. Lancet Gastroenterol Hepatol. 2016 Nov. 1(3):217-25. [Medline].

31. Klein AS, Hart J, Brems JJ, Goldstein L, Lewin K, Busuttil RW. Amanita poisoning: treatment and the role of liver transplantation. Am J Med. 1989 Feb. 86(2):187-93. [Medline].

32. Ichai P, Samuel D. Epidemiology of liver failure. Clin Res Hepatol Gastroenterol. 2011 Oct. 35(10):610-7. [Medline].

33. Bernal W, Wendon J. Acute liver failure. N Engl J Med. 2013 Dec 26. 369 (26):2525-34. [Medline].

34. Hoyer DP, Munteanu M, Canbay A, et al. Liver transplantation for acute liver failure: are there thresholds not to be crossed?. Transpl Int. 2014 Jun. 27(6):625-33. [Medline].

35. O'Grady JG, Alexander GJ, Hayllar KM, Williams R. Early indicators of prognosis in fulminant hepatic failure. Gastroenterology. 1989 Aug. 97(2):439-45. [Medline].

36. Lee WM, Galbraith RM, Watt GH, et al. Predicting survival in fulminant hepatic failure using serum Gc protein concentrations. Hepatology. 1995 Jan. 21(1):101-5. [Medline].

37. Schiodt FV, Rossaro L, Stravitz RT, et al, for the Acute Liver Failure Study Group. Gc-globulin and prognosis in acute liver failure. Liver Transpl. 2005 Oct. 11(10):1223-7. [Medline].

38. [Guideline] Chalasani NP, Hayashi PH, Bonkovsky HL, et al, for the Practice Parameters Committee of the American College of Gastroenterology. ACG clinical guideline: the diagnosis and management of idiosyncratic drug-induced liver injury. Am J Gastroenterol. 2014 Jul. 109(7):950-66; quiz 967. [Medline].

39. [Guideline] European Association for the Study of the Liver. Electronic address: easloffice@easloffice.eu. EASL clinical practical guidelines on the management of acute (fulminant) liver failure. J Hepatol. 2017 May. 66(5):1047-81. [Medline]. [Full Text].

40. Kelly JC. Drug-induced liver injury guidelines released by ACG. Medscape Medical News. Available at http://www.medscape.com/viewarticle/826952. June 18, 2014; Accessed: June 24, 2014.

41. Rolando N, Harvey F, Brahm J, et al. Fungal infection: a common, unrecognised complication of acute liver failure. J Hepatol. 1991 Jan. 12(1):1-9. [Medline].

42. Murphy N, Auzinger G, Bernel W, Wendon J. The effect of hypertonic sodium chloride on intracranial pressure in patients with acute liver failure. Hepatology. 2004 Feb. 39(2):464-70. [Medline].

43. Pereira SP, Langley PG, Williams R. The management of abnormalities of hemostasis in acute liver failure. Semin Liver Dis. 1996 Nov. 16(4):403-14. [Medline].

44. Stine JG, Lewis JH. Current and future directions in the treatment and prevention of drug-induced liver injury: a systematic review. Expert Rev Gastroenterol Hepatol. 2016. 10(4):517-36. [Medline].

45. [Guideline] Murray KF, Carithers RL Jr, AASLD. AASLD practice guidelines: Evaluation of the patient for liver transplantation. Hepatology. 2005 Jun. 41(6):1407-32. [Medline].

46. [Guideline] Martin P, DiMartini A, Feng S, Brown R Jr, Fallon M. Evaluation for liver transplantation in adults: 2013 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation. Hepatology. 2014 Mar. 59(3):1144-65. [Medline]. [Full Text].

47. [Guideline] Squires RH, Ng V, Romero R, et al. Evaluation of the pediatric patient for liver transplantation: 2014 practice guideline by the American Association for the Study of Liver Diseases, American Society of Transplantation and the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition. Hepatology. 2014 Jul. 60(1):362-98. [Medline]. [Full Text].

48. [Guideline] Lucey MR, Terrault N, Ojo L, et al. Long-term management of the successful adult liver transplant: 2012 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation. Liver Transpl. 2013 Jan. 19(1):3-26. [Medline]. [Full Text].

49. [Guideline] Kelly DA, Bucuvalas JC, Alonso EM, et al, for the American Association for the Study of Liver Diseases, American Society of Transplantation. Long-term medical management of the pediatric patient after liver transplantation: 2013 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation. Liver Transpl. 2013 Aug. 19(8):798-825. [Medline]. [Full Text].

50. ClinicalTrials.gov. Comparison of two extracorporeal liver support system (with or without recirculation): MARS (Molecular Adsorbents Recirculating System) versus SPAD (Single Pass Albumin Dialysis) in severe liver failure. Available at https://clinicaltrials.gov/ct2/show/NCT02310542. Accessed: June 5, 2017.

51. The effect of Prometheus liver support dialysis on cerebral metabolism in acute liver failure. ClinicalTrials.gov. Available at http://clinicaltrials.gov/ct2/show/NCT00655304. Accessed: August 30, 2011.

52. Fontana RJ, Ellerbe C, Durkalski VE, et al for the US Acute Liver Failure Study Group. Two-year outcomes in initial survivors with acute liver failure: results from a prospective, multicentre study. Liver Int. 2015 Feb. 35(2):370-80. [Medline].

53. Fairfield C, Penninga L, Powell J, Harrison EM, Wigmore SJ. Glucocorticosteroid-free versus glucocorticosteroid-containing immunosuppression for liver transplanted patients. Cochrane Database Syst Rev. 2015 Dec 15. 12:CD007606. [Medline].

54. Garcia Martinez JJ, Bendjelid K. Artificial liver support systems: what is new over the last decade?. Ann Intensive Care. 2018 Nov 15. 8(1):109. [Medline]. [Full Text].

Gagan K Sood, MD Associate Professor, Department of Medicine and Surgery, Baylor College of Medicine

Gagan K Sood, MD is a member of the following medical societies: American Association for the Study of Liver Diseases, American Gastroenterological Association

Disclosure: Nothing to disclose.

Steven A Conrad, MD, PhD Chief, Department of Emergency Medicine; Chief, Multidisciplinary Critical Care Service, Professor, Department of Emergency and Internal Medicine, Louisiana State University Health Sciences Center

Steven A Conrad, MD, PhD is a member of the following medical societies: American College of Chest Physicians, American College of Critical Care Medicine, American College of Emergency Physicians, American College of Physicians, International Society for Heart and Lung Transplantation, Louisiana State Medical Society, Shock Society, Society for Academic Emergency Medicine, Society of Critical Care Medicine

Disclosure: Nothing to disclose.

Lemi Luu, MD, RDMS, FACEP, FAAEM Attending Physician, Department of Emergency Medicine, Bridgeport Hospital, Yale-New Haven Health System

Lemi Luu, MD, RDMS, FACEP, FAAEM is a member of the following medical societies: American Academy of Emergency Medicine, American College of Emergency Physicians, American Institute of Ultrasound in Medicine

Disclosure: Nothing to disclose.

Mark S Slabinski, MD, FACEP, FAAEM Vice President, USACS Central

Mark S Slabinski, MD, FACEP, FAAEM is a member of the following medical societies: Alpha Omega Alpha, American Academy of Emergency Medicine, American College of Emergency Physicians, American Medical Association, Ohio State Medical Association

Disclosure: Nothing to disclose.

BS Anand, MD Professor, Department of Internal Medicine, Division of Gastroenterology, Baylor College of Medicine

BS Anand, MD is a member of the following medical societies: American Association for the Study of Liver Diseases, American College of Gastroenterology, American Gastroenterological Association, American Society for Gastrointestinal Endoscopy

Disclosure: Nothing to disclose.

David Eric Bernstein, MD Director of Hepatology, North Shore University Hospital; Professor of Clinical Medicine, Albert Einstein College of Medicine

David Eric Bernstein, MD is a member of the following medical societies: American Association for the Study of Liver Diseases, American College of Gastroenterology, American College of Physicians, American Gastroenterological Association, and American Society for Gastrointestinal Endoscopy

Disclosure: Nothing to disclose.

Oscar S Brann, MD, FACP Associate Clinical Professor, Department of Medicine, University of California at San Diego; Consulting Staff, Mecklenburg Medical Group

Oscar S Brann, MD, FACP is a member of the following medical societies: American Gastroenterological Association

Disclosure: Nothing to disclose.

Blake A Jones, MD New Hampshire Gastroenterology

Disclosure: Nothing to disclose.

Francisco Talavera, PharmD, PhD Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Medscape Salary Employment

Carin M Van Gelder, MD Assistant Professor, Department of Emergency Medicine, Yale University; EMS Medical Director, NHSHP and EMS Physician, SHARP Team; Attending Physician, Emergency Medicine, Yale-New Haven Medical Center

Carin M Van Gelder, MD is a member of the following medical societies: American Academy of Emergency Medicine, American College of Emergency Physicians, Massachusetts Medical Society, National Association of EMS Physicians, and Society for Academic Emergency Medicine

Disclosure: Nothing to disclose.

• Print this section
• Print the entire contents of
• Print the entire contents of article